Australia could look at more vaccine developers as current contracts underdeliver

The government has signed three major vaccine deals with AstraZeneca, Pfizer and the yet to be approved Novavax for a grand total of 124.8 million doses.

The AstraZeneca deal for 53.8 million doses with only 700,000 delivered from Europe and the Melbourne CSL manufacturing plant is yet to hit its goal of producing one million doses a week.

Australia is expected to get 20 million vaccines from the Pfizer deal over the course of the year also from Europe but the amount of vaccines delivered is unclear.

The Novavax deal has promised 51 million doses but they have not been approved by the TGA and are not expected to hit Australian shores until midyear at the earliest.

The government has signed three major vaccine deals with AstraZeneca, Pfizer and the yet to be approved Novavax for a grand total of 124.8 million doses.

The AstraZeneca deal for 53.8 million doses with only 700,000 delivered from Europe and the Melbourne CSL manufacturing plant is yet to hit its goal of producing one million doses a week.

Australia is expected to get 20 million vaccines from the Pfizer deal over the course of the year also from Europe but the amount of vaccines delivered is unclear.

The Novavax deal has promised 51 million doses but they have not been approved by the TGA and are not expected to hit Australian shores until midyear at the earliest.

Read Next

Source by [author_name]